MedTech Investing Conference Register Now! IBF Conferences – International Business Forum LifeScience Alley™ Home


Advisory Board


End of Speakers List

Conference Chairman

Don Gerhardt
Don Gerhardt
President & CEO
LifeScience AlleyTM
Prior to joining LifeScience Alley, Don was involved in the health care industry serving in top-level positions including: CEO of MedCenters Health Plan, administrator of Michigan State University medical facilities, Kaiser Permanente, a consultant for health care start-up companies and business coalitions, an officer for a high tech health care data company, and with several international health care businesses.  He currently sits on the board for two medical technology companies.  He is a frequent speaker and contributing writer to health care related articles and books.  His education includes Concordia College in Moorhead, Minnesota, a Masters degree in Health Administration from the University of Colorado, and postgraduate study in finance and statistics from Ohio State University.  He is a faculty member at the University of St. Thomas, and sits on the Advisory Boards of the University of Minnesota's Biomedical Engineering Institute, the College of Pharmacy, the Institute of Technology, and the School of Nursing.  Don also serves on the board of directors of Biomedical Commercialization Canada, Inc., the Bakken Museum, and the Greater Minneapolis Convention and Visitors Association. List of Advisory Board Members

Advisory Board Members

Josh Baltzell
Josh Baltzell
Director
Split Rock Partners
Josh Baltzell is a Managing Director at Split Rock Partners and has been with the firm since its inception in June 2004. Split Rock Partners is a venture firm focused on early stage investments in health care and software.  From 2002 to 2004, Mr. Baltzell was with St. Paul Venture Capital.  Prior to joining St. Paul Venture Capital, Mr. Baltzell was an investment banker at Piper Jaffray, where he focused primarily on mergers and acquisitions in the medical device sector.  Mr. Baltzell also held various marketing and business development positions with SCIMED/Boston Scientific.  Mr. Baltzell holds a B.A. in Economics from St. Olaf College and an M.B.A. from the University of Minnesota’s Carlson School of Management. List of Advisory Board Members
 
Chad Cornell
Chad Cornell
Vice President, Corporate Development
Medtronic, Inc.
Chad Cornell is Vice President of Corporate Development for Medtronic, Inc.   Chad has responsibility for supporting Medtronic’s CardioVascular business unit (vascular therapies and cardiac surgery therapies), as well as other strategic initiatives within Medtronic. Chad works in partnership with executive and business unit management in evaluating and executing mergers and acquisitions, strategic alliances, joint ventures, minority investments, technology licenses, divestitures and other strategic transactions. Chad also assists in Medtronic’s strategic planning process.

Prior to joining Corporate Development, Chad was Legal Counsel – M&A, responsible for advising Corporate Development on strategic transactions across Medtronic. Chad began his career with Medtronic in 2003. Prior to joining Medtronic, Chad spent approximately five years as an associate attorney at Sidley & Austin in Chicago, Illinois working on mergers and acquisitions and securities offerings.

Chad received his undergraduate degree in Accounting from Marquette University and a Juris Doctorate from the University of Pennsylvania. Chad has also successfully completed Certified Public Accountant and Chartered Financial Analyst examinations. List of Advisory Board Members
 
Mark E. DuVal
Mark E. DuVal
President
DuVal & Associates, P.A.
Mark E. DuVal, JD is President of DuVal & Associates, where he counsels both mature and venture-backed pharmaceutical, medical device, and biotech companies in the United States and Europe in addition to working extensively with combination products. DuVal regularly advises clients in all areas of FDA law and regulation, from product development, clinical trials, inspections and recalls to reimbursement and compliance issues and post-marketing responsibilities. He specializes in counseling medical device and pharmaceutical companies in the development and implementation of strategic and tactical sales and marketing plans that are appropriately aggressive, yet compliant. List of Advisory Board Members
 
Sami Hamadé
Sami Hamadé
Partner
Aberdare Ventures
Sami Hamadé joined Aberdare as a Partner in 2006.  Prior to Aberdare, Sami was Vice President at the Guidant Corporation and head of the Compass Group, where he was responsible for Guidant's venture capital and M&A activities.  Additionally, Sami led the West Coast Business Development unit which was composed of business development groups from Vascular Intervention, Cardiac Surgery and Endovascular Solutions divisions.  Previous to this, Sami played founding roles in the launch and development of significant businesses for Guidant including coronary stents, carotid and peripheral systems.  Sami began his career in medical devices at Advanced Cardiovascular Systems.  Sami holds a Bachelors degree in Engineering from the American University of Beirut, a Masters Degree in Engineering from the University of Michigan, Ann Arbor and an MBA from the Stanford Graduate School of Business. List of Advisory Board Members
 
William (Bill) Harrington
William (Bill) Harrington
Partner
Three Arch Partners
Bill has been with Three Arch Partners since 1999 and has been active in medical device health care service and biotechnology investing.  He currently sit on the boards of Cameron Health, NeuroVista, Satiety, Baxano, Benvenue, Centerre, APT Pharmaceuticals, and others.  Following medical school, Bill did his postgraduate training in internal medicine and diagnostic and interventional radiology at University of California, San Francisco.  Before joining Three Arch, he practiced as an interventional radiologist for nine years, and maintained a clinical faculty appointment at University of California, San Francisco.

He has broad experience with a wide variety of medical devices, minimally invasive surgical procedures, and related clinical trials.  He was a founder of Bay Medical Management.  Bill received his BS in Biology and Chemistry from Tufts University where he graduated summa cum laude.  He obtained his MD from Harvard Medical School.  He completed his MBA at the Haas School of Business at the University of California, Berkeley.  Bill is a CFA charter holder. List of Advisory Board Members

 
Thomas A. Letscher
Thomas A. Letscher
Partner and Co-Chair Medical Technology Group
Oppenheimer Wolff & Donnelly LLP
Tom Letscher practices in the areas of securities and corporate law and is a member of Oppenheimer’s policy committee.  His practice emphasizes advising medical technology and other emerging businesses with respect to: equity and debt financing (including private placements, venture capital financing, public offerings); mergers and acquisitions; corporate matters (including corporate governance, general corporate activities, duties and liabilities of officers and directors and advising boards of directors); strategic investments (including equity investments, options to acquire, distribution arrangements and licensing arrangements); acquisition and protection of intellectual property (including technology transfers, development agreements, licensing agreements and protection of trade secrets); securities matters (including preparation of Form 10-Ks, proxy statements and annual reports, compliance with SEC, NYSE and NASDAQ rules and disclosure issues.

Tom received his J.D. from Boalt Hall School of Law – University of California, Berkeley.  He also holds a B.S. in engineering from the University of Wisconsin. List of Advisory Board Members
 
Sam Nickerson
Sam Nickerson
Vice President
Investor Growth Capital
Sam joined Investor Growth Capital in 2008 as a Vice President with the Healthcare team focusing on biotechnology, specialty pharmaceuticals, and medical devices.  Prior to joining Investor Growth Capital, Sam spent five years with Tullis-Dickerson, a healthcare-focused venture capital firm, where he was responsible for sourcing and executing investments in medical technology, pharmaceuticals, diagnostics, and healthcare services companies.  Before joining Tullis-Dickerson, Sam held positions in finance and marketing at Bioject Medical Technologies.  He began his career at Sentinel Investments where he focused on investments in publicly traded healthcare companies.  Sam earned an M.B.A. from the University of Chicago and a B.A. in Biochemistry and Molecular Biology from Reed College.  He currently serves as a board member of Mpex Pharmaceuticals. List of Advisory Board Members
 
Zubeen Shroff
Zubeen Shroff
Managing Director
Galen Associates
Mr. Shroff is a Managing Director of Galen Partners, a leading healthcare private equity firm founded in 1990.  Prior to joining Galen in 1997, Mr. Shroff was a Principal at The Wilkerson Group, with a client base including pharmaceutical, diagnostic, device and biotech companies, plus a select number of venture capital firms.  He played a major role in developing several of The Wilkerson Group’s practice areas, including outcomes research, strategy formulation, and disease management initiatives.  Mr. Shroff was formerly at Schering-Plough France, where he directed the marketing, sales and Phase IV clinical development of the company’s high-growth biotech business.

Mr. Shroff currently serves on the board of directors of several Galen portfolio companies including Aperio Technologies, National Rehabilitation Equipment, ONI Medical Systems, Pet DRx, and Tactile Systems.  He is an Executive Committee member of Boston University’s Medical School Advisory Board and a member of the Westchester Medical Center Foundation Board.

Mr. Shroff earned a M.B.A. from the Wharton School and a B.A. biological science from Boston University. List of Advisory Board Members
 
Jonathan Silverstein
Jonathan Silverstein
General Partner
OrbiMed Advisors LLC
Mr. Silverstein is a General Partner of OrbiMed, as asset management firm solely focused in healthcare with more than $6 billion in assets under management.   Mr. Silverstein joined OrbiMed in 1998 to focus on private equity and structured transactions in small capitalization public biotechnology and medical device companies.  Mr. Silverstein was previously a Director of Life Sciences in the Investment Banking Department at Sumitomo Bank.  Mr. Silverstein has a J.D. and an M.B.A. from the University of San Diego, and a B.A. in Economics from Denison University.  Currently, Mr. Silverstein is a Director of Cerapedics, SuperDimension, Enobia, Gelesis and Insulet Corporation (PODD).  He has been a former director or observer in more than a dozen other companies including: LifeCell (LIFC), Given Imaging (GIVN), Cerexa (sold to Forest Labs), Peninsula Pharmaceuticals (sold to JNJ), Predix (sold to EPIX), Avanir (AVNR), Orthovita (VITA), Auxillium (AUXL), Bioenvision (sold to Genzyme), Adiana (sold to Cytyc), Adolor (ADLR) and Emphasys Medical. List of Advisory Board Members
 
Kathleen A Tune
Kathleen A Tune
Principal
Thomas McNerney Partners
Kathy joined Thomas, McNerney & Partners from Piper Jaffray, where she was a health care analyst focused on medical technology companies.  While at Piper, Kathy covered over 20 companies in the medical device, medical supply and diagnostic areas.  Her background also includes experience in new product development at Solvay, S.A. (in a division that is now part of Wyeth).  Projects at Solvay included the development of vaccines for the prevention of viral infections.  Kathy also was a Senior Scientist in molecular biology at the University of Minnesota, where she worked on the development of molecular biology based assays for the detection of infectious agents.  Kathy is currently a board member of Softscope Medical Technologies, Inc.  Her educational background includes an M.S. degree in Microbiology from the University of Minnesota and an M.B.A. from the University of Minnesota's Carlson School of Management, where she was a Robert and Gail Buuck Scholar. List of Advisory Board Members
 
Kevin Wasserstein
Kevin Wasserstein
Managing Director
Versant Ventures
Kevin Wasserstein is a Managing Director at Versant Ventures, a leading healthcare-focused venture capital firm targeting early-stage investments across healthcare.  Kevin brings more than fifteen years of venture capital and operating experience in medical device and high technology companies, and specializes in investing and building medical device companies from their earliest seed or concept stages through their entire life cycle.  Prior to joining Versant in 2002, Kevin served in a variety of marketing and business development roles at Guidant Corporation, including acting as the Director of Marketing in Guidant's Cardiac Surgery Group, and serving in Guidant's Compass Business Development Group, where he was involved in acquisition, licensing and investment activities with both private and public medical device companies, and in formulating corporate strategies to develop innovative medical technologies.  Kevin currently serves, or has served, in a variety of board or advisory roles with companies which include: Acclarent, Cellutions, LipoSonix, NDO Surgical, NeoGuide Systems, Rox Medical, Second Sight Medical, St. Francis Medical (sold) and The Innovation Factory.

Kevin holds both Bachelor's and Master's degrees in Mechanical Engineering, as well as an MBA, all from Stanford University. List of Advisory Board Members
 
Ralph Weinberger
Ralph Weinberger
Partner, Technology Industry Group
PricewaterhouseCoopers LLP
With over 24 years of service to life sciences and technology companies in the Twin Cities and Greater Minnesota, Ralph has worked with clients ranging in size from large global companies to high-growth small and mid-cap companies focused on developing into a global force.  In addition to coordinating delivery of high quality accounting and auditing services to his clients, Ralph has worked alongside his clients in addressing their needs for international expansion, mergers and acquisitions and accessing the public and private debt and equity markets.  Ralph is also the Treasurer of the Minnesota High Tech Association. List of Advisory Board Members

 
 
Internet marketing by AmazeMind.com